News & Press Releases

A team of attorneys in Mintz’s renowned Patent Litigation Practice, led by Intellectual Property Division Chair Michael Renaud, was recognized as a ‘Litigator of the Week Runner-Up’ by The Am Law Litigation Daily for securing a significant defense victory for Juul Labs at the US International Trade Commission. The article highlights that the “full commission affirmed an administrative law judge’s decision finding that Juul didn’t infringe upon patents held by Altria’s NJOY covering certain vaporizer and cartridge technology, preventing any potential exclusion order.”

Life Science Litigation Practice Chair and Patent Litigation Practice Co-chair Sige Gutman recently spoke with Life Sciences Intellectual Property Review about the latest federal developments impacting the US Patent and Trademark Office, including hiring freezes, layoffs, the elimination of non-essential functions, and a return-to-office directive. The article analyzes the potential implications of the changes, particularly for pharma and biotech companies, as patent pendency times are already increasing due to a high volume of recent applications.

ESG Practice Co-chair Jacob Hupart was quoted by Bloomberg Law in an article about how several states have introduced bills that would make large companies disclose their carbon emissions. 

International Life Sciences Chair Cheryl Reicin was quoted by Canadian Affairs in an article about how dental corporations have been consolidating a growing number of dental practices and the potential impacts on patients. 

Member Lauren Moldawer was quoted by Healthcare Brew on how pharmacy benefit managers (PBMs) are reacting to a proposed change to the Medicare Part D Program. This change would allow pharmacies to terminate contracts without cause and without permission from the PBM, which Lauren said could create uncertainty for PBMs. 

Member Lauren Moldawer spoke with Endpoints News about how the Trump administration might approach Medicare drug price negotiations under the Inflation Reduction Act (IRA) going forward.